Tehran University of Medical Sciences

Science Communicator Platform

Share By
Effects of Micrornas and Long Non-Coding Rnas on Chemotherapy Response in Glioma Publisher Pubmed



Ahmadpour S1 ; Taghavi T2 ; Sheida A3, 4 ; Tamehri Zadeh SS5 ; Hamblin MR6 ; Mirzaei H7
Authors

Source: Epigenomics Published:2022


Abstract

Glioma is the most prevalent invasive primary tumor of the central nervous system. Glioma cells can spread and infiltrate into normal surrounding brain tissues. Despite the standard use of chemotherapy and radiotherapy after surgery in glioma patients, treatment resistance is still a problem, as the underlying mechanisms are still not fully understood. Non-coding RNAs are widely involved in tumor progression and treatment resistance mechanisms. In the present review, we discuss the pathways by which microRNAs and long non-coding RNAs can affect resistance to chemotherapy and radiotherapy, as well as offer potential therapeutic options for future glioma treatment. © 2022 Future Medicine Ltd.
1. Novel Management of Glioma by Molecular Therapies, a Review Article, European Journal of Translational Myology (2019)
2. Quercetin and Glioma: Which Signaling Pathways Are Involved?, Current Molecular Pharmacology (2022)
Experts (# of related papers)
Other Related Docs
15. Exosomal Noncoding Rnas: Key Players in Glioblastoma Drug Resistance, Molecular and Cellular Biochemistry (2021)
18. Non-Coding Rnas and Brain Tumors: Insights Into Their Roles in Apoptosis, Frontiers in Cell and Developmental Biology (2022)